{"id":"W3168988530","doi":"10.1016/j.jval.2021.04.019","title":"CN4 Patient-Reported Outcomes from the Phase 3, Randomized Study of Acalabrutinib with or without Obinutuzumab Versus Chlorambucil PLUS Obinutuzumab for Treatment-Naïve Chronic Lymphocytic Leukemia (ELEVATE-TN)","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Obinutuzumab; Chlorambucil; Medicine; Internal medicine; Chronic lymphocytic leukemia; Randomized controlled trial; Quality of life (healthcare); Oncology; Gastroenterology; Leukemia; Chemotherapy; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002929906,0.001401183,0.002165575,0.0004861447,0.0005284205,0.00104126,0.001286614,0.001076071,0.007682316],"category_scores_gemma":[0.003478487,0.0003814068,0.005131262,0.0007057583,0.000655886,0.001023035,0.0007535532,0.00284822,0.0005913427],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001660055,"about_ca_system_score_gemma":0.002052398,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004408684,"about_ca_topic_score_gemma":0.0102043,"domain_scores_codex":[0.9982523,0.001035987,0.00008631402,0.0002237242,0.0001730575,0.000228653],"domain_scores_gemma":[0.9973075,0.0009170704,0.0008085038,0.0001932879,0.0002332603,0.0005403087],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9528486,0.001650136,0.009404227,0.001099985,0.01127456,0.00005756511,0.00003961395,0.001325857,0.001102465,0.0002281657,0.004431708,0.0165372],"study_design_scores_gemma":[0.8715861,0.04837049,0.05790792,0.0002499429,0.01361457,0.0001389231,0.00008902534,0.001515024,0.0008110573,0.0007399732,0.004907843,0.00006920438],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9619177,0.01020703,0.0008115897,0.0009251866,0.0004627338,0.001391837,0.01877018,0.00008409684,0.005429677],"genre_scores_gemma":[0.9724556,0.002441983,0.0009781397,0.001280675,0.000305405,0.001921407,0.01662165,0.00003396092,0.003961201],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007682316,"threshold_uncertainty_score":0.02569991,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1106549774328644,"score_gpt":0.3871581889329666,"score_spread":0.2765032115001023,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}